For the past three years, nearly every breakthrough in obesity medicine has traced back to a single class of drugs: GLP-1 ...

Some experts believe that anyone could benefit from GLP-1 medications, as the popular drugs have become more widespread and accessible. Others, however, warn that the decision to take the diabetes and ...

Incretin-based obesity medications may result in higher muscle-related loss vs. other weight loss strategies, according to data published in Annals of Internal Medicine.The findings “suggest that ...

An experimental oral drug claims to do the work of medications like GLP-1s without losing muscle mass. The medication just went through phase 1 clinical trials. Doctors explain the new medication and ...

The diabetes drug Mounjaro will be tested alongside an experimental treatment to study how to maintain muscle mass while losing weight, according to an announcement Thursday—after earlier studies ...

Altimmune said its experimental drug in a midstage trial helped patients shed weight but also minimized the loss of muscle mass. Altimmune is one of several smaller biotech companies pushing to ...

A new study offers fresh hope for people living with type 2 diabetes and obesity. Researchers report progress toward a pill that lowers blood sugar and boosts fat burning without cutting appetite or ...

Rapid weight loss affects muscle mass and can increase the risk of osteoporosis. But now there is good news for people taking weight loss medication who may be at risk. A new study indicates that the ...

For a little over a century, modern weight loss medications have worked to provide a slimming solution that mature adults can count on. Subsequently, reduction drugs such as glucagon-like peptide-1 ...

New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health. The experimental agent, known as AR-42 while ...